Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

ACCOUNTS PAYABLE AND ACCRUED LIABILITIES

v3.24.3
ACCOUNTS PAYABLE AND ACCRUED LIABILITIES
 6 Months Ended
Jun. 30, 2024
Payables and Accruals [Abstract]  
ACCOUNTS PAYABLE AND ACCRUED LIABILITIES

NOTE 6. ACCOUNTS PAYABLE AND ACCRUED LIABILITIES

 

The Company’s accounts payable and accrued liabilities consist of the following:

 

    June 30, 2024     December 31, 2023  
Accounts payable   £ 942,267     £ 1,847,279  
Other tax and social security     175,392       139,029  
Accrued expenses     915,268       1,229,419  
Amounts accrued in respect to clinical trial testing     1,177,500       1,177,500  
Other payables     1,263       38,613  
Total   £ 3,211,690     £ 4,431,840  

 

The fair value of accounts payable are not materially different to the book value.